Onkure Therapeutics, Stock Alpha and Beta Analysis
| OKUR Stock | 8.38 0.33 4.10% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as OnKure Therapeutics,. It also helps investors analyze the systematic and unsystematic risks associated with investing in OnKure Therapeutics, over a specified time horizon. Remember, high OnKure Therapeutics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to OnKure Therapeutics,'s market risk premium analysis include:
Beta 0.23 | Alpha (0.81) | Risk 4.26 | Sharpe Ratio (0.16) | Expected Return (0.67) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
OnKure |
OnKure Therapeutics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. OnKure Therapeutics, market risk premium is the additional return an investor will receive from holding OnKure Therapeutics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in OnKure Therapeutics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate OnKure Therapeutics,'s performance over market.| α | -0.81 | β | 0.23 |
OnKure Therapeutics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of OnKure Therapeutics,'s Buy-and-hold return. Our buy-and-hold chart shows how OnKure Therapeutics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.OnKure Therapeutics, Market Price Analysis
Market price analysis indicators help investors to evaluate how OnKure Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OnKure Therapeutics, shares will generate the highest return on investment. By understating and applying OnKure Therapeutics, stock market price indicators, traders can identify OnKure Therapeutics, position entry and exit signals to maximize returns.
OnKure Therapeutics, Return and Market Media
The median price of OnKure Therapeutics, for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 is 16.6 with a coefficient of variation of 17.75. The daily time series for the period is distributed with a sample standard deviation of 2.8, arithmetic mean of 15.8, and mean deviation of 2.09. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Saccomano Nicholas A of 4556 shares of OnKure Therapeutics, subject to Rule 16b-3 | 10/08/2024 |
2 | Acquisition by Leonard Braden Michael of 3457 shares of OKUR New subject to Rule 16b-3 | 10/09/2024 |
3 | This Builders FirstSource Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Thursday | 10/10/2024 |
4 | Acquisition by Manke Isaac of 15300 shares of OnKure Therapeutics, at 18.2 subject to Rule 16b-3 | 10/18/2024 |
5 | OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium | 11/01/2024 |
6 | Acquisition by Jansen Valerie Malyvanh of 15300 shares of OnKure Therapeutics, at 18.2 subject to Rule 16b-3 | 11/22/2024 |
7 | OnKure Announces New Date for Upcoming Investor Call | 11/25/2024 |
8 | OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic Data from its First-In-Human PIKture-01 Trial of OKI-219 | 12/10/2024 |
About OnKure Therapeutics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including OnKure or other stocks. Alpha measures the amount that position in OnKure Therapeutics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards OnKure Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, OnKure Therapeutics,'s short interest history, or implied volatility extrapolated from OnKure Therapeutics, options trading.
Build Portfolio with OnKure Therapeutics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.